MARKET

ELMD

ELMD

ELECTROMED
AMEX

Real-time Quotes | Nasdaq Last Sale

9.35
+0.23
+2.52%
Opening 13:53 10/22 EDT
OPEN
9.14
PREV CLOSE
9.12
HIGH
9.35
LOW
8.93
VOLUME
56.31K
TURNOVER
--
52 WEEK HIGH
19.73
52 WEEK LOW
6.61
MARKET CAP
80.42M
P/E (TTM)
19.85
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
How Much Does Electromed's (NYSEMKT:ELMD) CEO Make?
Kathleen Skarvan has been the CEO of Electromed, Inc. (NYSEMKT:ELMD) since 2012, and this article will examine the...
Simply Wall St. · 3h ago
Is Electromed (ELMD) a Smart Long-term Buy?
Summers Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of -1.2% in the first nine months of 2020, outperforming its benchmark, the Russell 2000 Index which returned -9.6% in the same period. You should check out Summers Value Partners’ top 5 […]
Insider Monkey · 5d ago
Summers Value Partners Q3 2020 Investor Letter
Summers Value Partners is a boutique value manager that uses a focused, long-term approach to investing in areas of the market where most managers are unwilling or unable to participate.The Summers Value Fund LP declined by 1.2% net during the first nine months of 2020, outpacing the Russell 2000 Index return of -9.6% and the Russell Microcap Index return of -9.1%.Our shorting activities continue to be limited as we wait for better opportunities. The Fund has generated a small loss on the short side year-to-date.We currently have more ideas than we do capital. We added two new positions in the third quarter, and our idea funnel remains full.
Seekingalpha · 6d ago
Aduro Biotech, American Renal Associates leads healthcare gainers; Benitec Biopharma, Mesoblast among major losers
Gainers: Aduro Biotech (ADRO) +442%, American Renal Associates (ARA) +69%, Nano-X Imaging (NNOX) +38%, CTI BioPharma (CTIC) +18%, ProPhase Labs (PRPH) +16%.Losers: Benitec Biopharma (BNTC) -36%, Mesoblast (MESO) -36%, Arcutis Biotherapeutics (ARQT) -14%, PDL BioPharma (PDLI) -13%, Electromed (ELMD) -12%.
Seekingalpha · 10/02 14:56
Electromed, Inc.'s (NYSEMKT:ELMD) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/E Ratio
The Electromed, Inc. (NYSEMKT:ELMD) share price has fared very poorly over the last month, falling by a substantial...
Simply Wall St. · 09/22 11:51
Electromed (ELMD) Has Risen 89% in Last One Year, Outperforms Market
If you are looking for the best ideas for your portfolio you may want to consider some of Summers Value Partners top stock picks. Summers Value Partners, an investment management firm, is bullish on Electromed Inc. (NYSE:ELMD) stock. In its Q2 2019 investor letter – you can download a copy here – the
Insider Monkey · 09/09 15:35
Subdued Growth No Barrier To Electromed, Inc.'s (NYSEMKT:ELMD) Price
With a price-to-earnings (or "P/E") ratio of 24.7x Electromed, Inc. (NYSEMKT:ELMD) may be sending bearish signals at...
Simply Wall St. · 09/03 12:29
Electromed, Inc. to Participate in the 2020 Colliers Institutional Investor Conference
Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the
Business Wire · 08/26 21:30
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ELMD. Analyze the recent business situations of ELECTROMED through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ELMD stock price target is 19.00 with a high estimate of 19.00 and a low estimate of 19.00.
EPS
Institutional Holdings
Institutions: 23
Institutional Holdings: 2.17M
% Owned: 25.27%
Shares Outstanding: 8.60M
TypeInstitutionsShares
Increased
5
98.26K
New
2
23.76K
Decreased
5
33.16K
Sold Out
4
31.21K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.72%
Healthcare Equipment & Supplies
+2.23%
Key Executives
Chairman/Director
Stephen Craney
President/Chief Executive Officer/Director
Kathleen Skarvan
Chief Financial Officer
Michael MacCourt
Independent Director
Stan Erickson
Independent Director
Gregory Fluet
Independent Director
Lee Jones
Independent Director
George Winn
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ELMD
Electromed, Inc. develops, manufactures and markets airway clearance products, which apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The Company's products include the SmartVest Airway Clearance System (SmartVest System), the SmartVest SQL System and others. As of June 30, 2016, the SmartVest System is available in two models: SV2100 and SQL. The SmartVest System consists of an inflatable therapy garment, a programmable air pulse generator and a single-hose, which delivers air pulses from the generator to the garment. The SmartVest SQL System is small, quiet and light, and offers generator programmability. The Company markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to healthcare providers, particularly those working in intensive care units. The Company sells its products to the home healthcare market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis and neuromuscular disease.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Electromed, Inc. stock information, including AMEX:ELMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ELMD stock methods without spending real money on the virtual paper trading platform.